Literature DB >> 34543094

Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells.

Frédéric Peyrusson1, Adam O Whelan2, Margaret G Hartley2, Isobel H Norville2, Sarah V Harding2, Françoise Van Bambeke1.   

Abstract

We evaluated antibiotic activity against the intracellular bacterium Coxiella burnetii using an activated THP-1 cell model of infection. At clinically relevant concentrations, the intracellular bacterial load was reduced 300-fold by levofloxacin and finafloxacin, 40-fold by doxycycline, and 4-fold by ciprofloxacin and was unaffected by azithromycin. Acidification of the culture medium reduced antibiotic activity, with the exceptions of doxycycline (no change) and finafloxacin (slight improvement). This model may be used to select antibiotics to be evaluated in vivo.

Entities:  

Keywords:  Coxiella; azithromycin; ciprofloxacin; doxycycline; finafloxacin; intracellular infection; levofloxacin

Mesh:

Substances:

Year:  2021        PMID: 34543094      PMCID: PMC8597764          DOI: 10.1128/AAC.01061-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm.

Authors:  M Maurin; A M Benoliel; P Bongrand; D Raoult
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

2.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

3.  Life-threatening Q fever infection following exposure to kangaroos and wallabies.

Authors:  Sarah Stevenson; John Gowardman; Sarah Tozer; Marion Woods
Journal:  BMJ Case Rep       Date:  2015-09-17

4.  Use of axenic media to determine antibiotic efficacy against coxiella burnetii.

Authors:  K A Clay; M G Hartley; P Russell; I H Norville
Journal:  Int J Antimicrob Agents       Date:  2017-08-09       Impact factor: 5.283

5.  Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.

Authors:  Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens
Journal:  Int J Antimicrob Agents       Date:  2011-05-18       Impact factor: 5.283

6.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

Authors:  M R Yeaman; L A Mitscher; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

7.  Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.

Authors:  Sébastien Van de Velde; Hoang Anh Nguyen; Françoise Van Bambeke; Paul M Tulkens; Jean Grellet; Véronique Dubois; Claudine Quentin; Marie-Claude Saux
Journal:  J Antimicrob Chemother       Date:  2008-06-10       Impact factor: 5.790

8.  Efficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.

Authors:  I H Norville; G J Hatch; K R Bewley; D J Atkinson; K A Hamblin; J D Blanchard; S J Armstrong; J K Pitman; E Rayner; G Hall; J Vipond; T P Atkins
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

9.  Coxiella burnetii: A Pathogenic Intracellular Acidophile.

Authors:  Edward I Shaw; Daniel E Voth
Journal:  Microbiology (Reading)       Date:  2018-11-13       Impact factor: 2.777

10.  Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin and Co-trimoxazole using in vitro and in vivo models of Q fever.

Authors:  K A Clay; M G Hartley; S Armstrong; K R Bewley; K Godwin; E Rayner; J Vipond; M Bailey; T P Atkins; I H Norville
Journal:  Antimicrob Agents Chemother       Date:  2021-08-09       Impact factor: 5.191

View more
  3 in total

1.  Antibiotic persistence of intracellular Brucella abortus.

Authors:  Selma Mode; Maren Ketterer; Maxime Québatte; Christoph Dehio
Journal:  PLoS Negl Trop Dis       Date:  2022-07-26

2.  Investigation of a combination therapy approach for the treatment of melioidosis.

Authors:  Kay B Barnes; Mark I Richards; Gary Burgess; Stuart J Armstrong; Christine Bentley; Thomas C Maishman; Thomas R Laws; Michelle Nelson; Sarah V Harding
Journal:  Front Microbiol       Date:  2022-08-16       Impact factor: 6.064

Review 3.  Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline.

Authors:  Béla Kocsis; Dániel Gulyás; Dóra Szabó
Journal:  Antibiotics (Basel)       Date:  2021-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.